Friedreich's Ataxia Research Alliance (FARA)
Caitlin Monette has a diverse work experience spanning different roles and companies. Caitlin currently holds the position of Director of Clinical Operations at the Friedreich's Ataxia Research Alliance (FARA) since September 2022. Previously, they worked at Metavention, Inc. from 2019 to 2022, where they held the roles of Clinical Project Manager and Senior Clinical Research Associate. From 2017 to 2019, they worked as a Clinical Research Associate II at Johnson & Johnson. Prior to that, they worked at Torax Medical, Inc. from 2014 to 2017, serving as a Clinical Research Associate II and Clinical Data Coordinator. Caitlin also worked at the Minnesota Epilepsy Group as a Research Assistant/Back-up Study Coordinator from 2011 to 2014, and at the Memorial Blood Centers as a Clinical Lab Scientist II from 2010 to 2011. Caitlin'searly career started at Dunn Bros Coffee, where they worked as a Barista from 2005 to 2008.
Caitlin Monette obtained their Bachelor of Science degree in Genetics and Cellular Development from the University of Minnesota from 2007 to 2009. Prior to that, they received an Associate degree in Arts from Inver Hills Community College from 2005 to 2007. In November 2014, they obtained the CCRC certification from the ACRP - Association of Clinical Research Professionals.
This person is not in any offices
Friedreich's Ataxia Research Alliance (FARA)
The Friedreich's Ataxia Research Alliance (FARA) is a national, public, 501(c)(3), non-profit, tax-exempt organization dedicated to curing Friedreich’s ataxia (FA) through research. FARA grants and activities provide support for basic and translational FA research, pharmaceutical/ biotech drug development, clinical trials, and scientific conferences. FARA also serves as a catalyst, between the public and scientific community, to create worldwide exchanges of information that drive medical advances. FARA was founded in September 1998 by a group of patient families and three of the world’s leading FA scientists — Drs. Rob Wilson, Bronya Keats, and Massimo Pandolfo. It was staffed and managed as an all volunteer organization until late 2005. FARA's leadership and numerous patient families and friends have raised critical funds over the years to support FA research. Thanks to the brilliant and committed efforts of many FA scientists, we now understand the cause of FA and specific mechanisms leading to damage in FA patients. These understandings allow for more targeted approaches to treatment which are currently being developed for clinical trials.